Intracerebroventricular Infusions of Angiotensin II Increases Sodium Excretion

Virginia L. Brooks, Richard L. Malvin

Research output: Contribution to journalArticlepeer-review

30 Scopus citations


The mechanism by which intracerebroventricular administration of angiotensin II (AII) enhances renal sodium excretion was studied in anesthetized dogs. Intraventricular infusion of AII (6 ng/min) increased sodium excretion independently of changes in renal plasma flow (RPF), glomerular filtration rate (GFR), blood pressure (BP), and plasma concentration of aldosterone. In order to evaluate the intracerebral role of endogenous AII in the control of sodium excretion, the converting enzyme inhibitor, SQ20881 (0.5 μg/min), was infused intraventricularly in another group of dogs. This infusion decreased sodium excretion; in addition, there were no changes in RPF, GFR, BP, and plasma aldosterone concentration. The mechanism of the antinatriuresis remains unclear. However, the fact that SQ20881 administration decreased sodium excretion is consistent with the hypothesis that endogenous AII is tonically active in the brain to stimulate sodium excretion.

Original languageEnglish (US)
Pages (from-to)532-537
Number of pages6
JournalProceedings of the Society for Experimental Biology and Medicine
Issue number4
StatePublished - Apr 1982
Externally publishedYes

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology


Dive into the research topics of 'Intracerebroventricular Infusions of Angiotensin II Increases Sodium Excretion'. Together they form a unique fingerprint.

Cite this